AILA RAWLINS: Open Payments
NPI 1033667977 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,799 in 64 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $292 · 2025 $1,799
Food & beverage: $1,587Education: $213
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 20 | $646 |
| AstraZeneca Pharmaceuticals LP | 14 | $449 |
| GENZYME CORPORATION | 9 | $217 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $83 |
| Genentech USA, Inc. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Grifols USA, LLC | 2 | $53 |
| Amgen Inc. | 2 | $53 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Lilly USA, LLC | 2 | $46 |
Products named: DUPIXENT, AIRSUPRA, BREZTRI, TEZSPIRE, NEFFY, Xolair, Prolastin-C Liquid, EBGLYSS.
Industry payments across FL — which companies pay providers there.
